SECONDARY ACUTE MYELOID LEUKEMIA
Clinical trials for SECONDARY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for SECONDARY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New attack on stubborn leukemia before transplant
Disease control Not yet recruitingThis study tests if combining different chemotherapy drugs can better eliminate leftover leukemia cells in adults aged 18-59 before they receive a stem cell transplant. Participants will receive one of four treatment plans, including standard care or newer combinations. The goal …
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
New hope for hard-to-treat leukemia: three-drug combo targets relapsed AML
Disease control Not yet recruitingThis study tests a combination of three drugs (cladribine, low dose cytarabine, and venetoclax) in 24 adults with acute myeloid leukemia (AML) that has relapsed or not responded to prior treatment, especially after a venetoclax-based regimen. The goal is to see if this combinatio…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 17, 2026 12:04 UTC
-
New combo therapy offers hope for Hard-to-Treat leukemia patients
Disease control Not yet recruitingThis study tests a two-step approach for adults with a rare or treatment-related form of acute myeloid leukemia (AML). First, patients receive a combination of two drugs (venetoclax and azacitidine) to reduce cancer cells. Then, they receive a stem cell transplant from a donor to…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC